JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia.

Zecca, M; Bergamaschi, G; Kratz, C; Bergsträsser, E; Danesino, C; De Filippi, P; Hasle, H; Lisini, D; Locatelli, F; Pession, A; Sainati, L; Starý, J; Trebo, M; van den Heuvel-Eibrink, M; Wójcik, D; Niemeyer, C M

Zecca, M; Bergamaschi, G; Kratz, C; Bergsträsser, E; Danesino, C; De Filippi, P; Hasle, H; Lisini, D; Locatelli, F; Pession, A; Sainati, L; Starý, J; Trebo, M; van den Heuvel-Eibrink, M; Wójcik, D; Niemeyer, C M.

Leukemia ; 21(2): 367-9, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17151700

Subject(s)

Amino Acid Substitution; Janus Kinase 2/genetics; Leukemia, Myelomonocytic, Acute/genetics; Leukemia, Myelomonocytic, Chronic/genetics; Mutation; Child; Child, Preschool; Chromosome Aberrations; Female; Humans; Infant; Karyotyping; Male

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelomonocytic, Acute / Leukemia, Myelomonocytic, Chronic / Amino Acid Substitution / Janus Kinase 2 / Mutation Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Leukemia Year: 2007 Document type: Article

Search on Google

XML

PubMed Links